Newsletter Login

Username:

Password:


Need help logging in?

New Subscriber?
Start Here!

Stock Spotlight

Centene makes Medicaid pay

Recent Price
$67
Dividend
$0.00
Yield
0.0%
P/E Ratio
15
Shares (millions)
176
Long-Term Debt as % of Capital
43%
52-Week Price Range
$75.57 - $50.00



Shares of Centene ($67; CNC), the largest private Medicaid administrator, have rallied 28% in 2017, ahead of the 7% gain for the S&P 500 Index. Only one S&P 500 health insurer has staged a stronger rally.

Despite the recent rally, Centene's prospects look bright. And concerns regarding the fate of the Affordable Care Act seem well reflected in the insurer's share price. Centene, with a Quadrix Value score of 95, is a Focus List Buy and a Long-Term Buy.

Unique market position

Centene has 11.4 million medical members, broken down as follows:

• 6.9 million for Medicaid.

• 2.8 million for the military program TRICARE.

• 1.2 million for commercial plans.

• 334,300 for Medicare.

• 39,400 for correctional facilities.

Uncertainty over the future of the Affordable Care Act poses a risk for all health insurers. Unlike most insurers, Centene has turned a profit from the ACA exchanges. State and federal exchanges accounted for 540,000 of Centene's members at the end of 2016, down from 680,000 members at the end of March, due to expected attrition. As rivals scale back on exposure to exchanges, Centene scooped up more than 1 million members during the 2017 open enrollment period. Centene says the risk profile for these individuals is similar to previous years.

Centene's Medicaid membership has more than doubled since ACA launched in 2014, pushing its share to a leading 13% slice of the highly fragmented market. The U.S. expects Medicaid spending to rise at an average annual rate of 6% over the next decade to reach $973 billion by 2025.

Congress has yet to disclose its strategy for handling the ACA. The program's popularity would put lawmakers in a tough spot if they repealed it without a replacement or devised an alternative that caused a large swath of Americans to lose their existing insurance.

With a stock-market value of $12.7 billion, Centene is dwarfed by the other five managed-care companies in the S&P 500, including Humana, the second-smallest insurer at more than $21.5 billion. Given its recent deal to purchase HealthNet, Centene may view itself as an acquirer rather than takeover target. But Centene's Medicaid business and relatively small size may lure potential suitors.

Conclusion

As witnessed by Centene's rocky September quarter, the HealthNet integration can create temporary speed bumps. Yet the stock's low valuation may signal undue pessimism. Centene shares look cheap at 17 times trailing earnings, versus the average of 19 for S&P 500 health insurers. Centene is the only stock in its industry to trade below its five-year average P/E.

Per-share profits are projected to climb 40% in the March quarter, with growth stoked by Centene's $6 billion acquisition of HealthNet, completed in March 2016. For the year, Centene's profits are expected to climb 6%, and estimates have crept higher over the past 60 days. At 15 times estimated 2017 earnings, the stock trades 5% below its industry average.

An annual report for Centene Corp. can be obtained at 7700 Forsyth Blvd., St. Louis, MO 63105, (314) 725-4477, www.centene.com.


 

Centene

 
Quarter
Per-Share Earnings
Sales Change
Quarterly Price Range
P/E Ratio Range
Dec '16
$1.19
vs.
$0.97
86%
$72.75
-
$59.65
18 - 15
Sep '16
1.11
vs.
0.87
86%
75.57
-
55.60
20 - 14
Jun '16
1.29
vs.
0.76
98%
66.96
-
47.36
20 - 14
Mar '16
0.74
vs.
0.55
36%
68.42
-
53.92
22 - 17

 
Year (Dec)
Sales (Bil.)
Per-Share Earnings*
Per-Share Dividend
52-Week Price Range
P/E Ratio Range
2016
$40.41
$4.43
$0.00
$75.57
-
$47.36
17 - 11
2015
22.76
3.14
0.00
83.00
-
50.93
26 - 16
2014
16.56
2.26
0.00
54.24
-
27.56
24 - 12
2013
10.86
1.47
0.00
33.92
-
20.28
23 - 14

 
Quadrix Scores†
Overall
Momentum
Value
Quality
Financial Strength
Earnings Estimates
Performance
96
92
95
91
27
29
54

* Earnings exclude special items.
NA Not Available.
† Quadrix® scores are percentile ranks, with 100 the best.
e Dividend and yield estimated.

More Investment Newsletters and Services

Drip Investor

DRIP Investor — how you can buy dividend-paying stocks without a broker.

Visit us at DRIP Investor, your source for dividend reinvestment plans.

Lazy Investor

The Lazy Investor — free weekly e-letter that delivers market updates and stock market information via email.

Visit us at The Lazy Investor, our free investment newsletter.

Horizon Investment

Horizon — registered investment advisor seeks to provide investors at all stages the ability to build, preserve and enjoy wealth.

Visit us at Horizon Investment Services to get started in an investment program that's right for you.

Upside

Upside — discovers today's small and midcap stocks poised to be tomorrow's Blue Chip leaders.

Visit us at Upside, your guide to the best buys in small and midcap stocks.

Current Hotline

Friday, March 24, 2017

During the first four days of this week, the S&P 1500 Index declined 1.5%

Read More from the Hotline

Stock Spotlight

Centene makes Medicaid pay

Wednesday, March 22, 2017

Shares of Centene ($67; CNC), the largest private Medicaid administrator, have rallied 28% in 2017, ahead of the 7% gain for the S&P 500...

Read More from Stock Spotlight

Individual Stock Reports

ISRs make stock research easy!

Perhaps the most valuable two page reports available anywhere.

All the data you would normally have to plow through years of 10-K filings, earnings reports, and reams of market data to assemble — yours all in one concise report.

ISRs contain our proprietary Quadrix scores — find out how we rate all the stocks in the S&P 500.

Visit us at individualstockreports.com